Skip to main content

IMCD acquires on three continents

Speciality chemicals distributor IMCD has made buys in North America, Europe and Asia in the space of four days. It has completed the previously announced acquisition of Horn in the US, plus DCS Pharma in Switzerland and a majority stake in South Korean Whawon Pharm.

ROMEO, ROMEO...

Evonik and nine partners in the ROMEO (Reactor Optimisation by Membrane-Enhanced Operation) project have succeeded in developing catalysing oxo reactions, in which olefins are converted into aldehydes with synthesis gas in a hydroformylation reaction.

Two invest in lithium hydroxide

The two largest players in lithium chemistry have both made significant investments in the past month, with Albemarle closing a deal that gives it a stake in a spodumene mine in Western Australia and Livent has begun construction of more lithium hydroxide production in the US.

Rheticus: Evonik and Siemens launch phase II

Evonik and Siemens have launched their joint research project Rheticus II, which seeks to develop an efficient and powerful test plant that will develop speciality chemicals from CO2, water, renewable electricity and bacteria.

Azelis buys in Turkey and Lebanon

Azelis has agreed to acquire Ekin Kimya, a major Turkish distributor of speciality chemicals, pharmaceutical and lab chemicals and food ingredients, from Aktas Dıs Ticaret and individual shareholders.

Arkema brings two expansions onstream

Arkema has announced that it has brought a new 90,000 tonnes/year acrylic acid reactor at its site in Clear Lake, Texas, at a cost of about $90 million. This replaces two 45,000 tonnes/year reactors, which have been decommissioned.

Piedmont Lithium speeds up plans

Piedmont Lithium has said that it is accelerating the development of its lithium chemical plant in the Carolina Tin-Spodumene Belt, near Charlotte, which is claimed to be tone of the world’s best lithium sources.
Subscribe to Current issue

 

AMRI - The Expertise You Need